Evidence map›Paper›PMID 30221153›Full record

ArticleHepatobiliary surgery and nutrition2018

Effectiveness of additional resection of the invasive cancer-positive proximal bile duct margin in cases of hilar cholangiocarcinoma.

Wen-Jie Ma, Zhen-Ru Wu, Anuj Shrestha, Qin Yang, Hai-Jie Hu, Jun-Ke Wang, Fei Liu, Rong-Xing Zhou, Quan-Sheng Li, Fu-Yu Li

Abstract read
In one paragraph

Article in Hepatobiliary surgery and nutrition, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Surgical Strategies for Bismuth Type I and II Hilar Cholangiocarcinoma: Impact on Long-Term Outcomes.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2021
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wen-Jie MaDepartment of Biliary Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Zhen-Ru WuLaboratory of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China.
Anuj ShresthaDepartment of Biliary Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Qin YangDepartment of Biliary Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Hai-Jie HuDepartment of Biliary Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Jun-Ke WangDepartment of Biliary Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Fei LiuDepartment of Biliary Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Rong-Xing ZhouDepartment of Biliary Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Quan-Sheng LiDepartment of Biliary Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Fu-Yu LiDepartment of Biliary Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe survival benefits of additional resection of the positive proximal ductal margin (PM) in hilar cholangiocarcinoma (HCCA) remains controversial. This retrospective study investigated the effectiveness of additional resection of the invasive cancer PM under different levels of preoperative carbohydrate antigen 19-9 (CA19-9).

methodsPatients who underwent hepatectomy for HCCA from 2000 to 2017 were analyzed. Surgical variables, resection margin status, length of the PM (LPM), prognostic factors, and survival were evaluated.

resultsA total of 228 patients were enrolled: 175 PM(-) without additional resection patients (group A), 21 PM(-) after additional resection (group B), 16 PM(+) without additional resection (group C), and 16 PM(+) after additional resection (group D). The median survival of group B (20.99 months) was similar to that of group A (23.00 months; P=0.16), and both were significantly better than those of group C (11.60 months) and D (9.50 months), especially when preoperative CA19-9>150 U/mL (P<0.05). The survival of patients with an LPM >10 mm was significantly better compared with those with an LPM ≤10 mm, especially when preoperative CA19-9 was >150 U/mL (P<0.05). Only in the LPM >10 mm group, the survival of group B was comparable with that of group A (P>0.05).

conclusionsHCCA patients could get a survival benefit from a negative PM resulting from additional resection. Survival could be comparable with that of negative PM without additional resection among HCCA patients. An LPM >10 mm is possibly more associated with better survival compared with whether additional resection of the positive PM is performed under different levels of preoperative CA19-9.

Indexed as

antigens, neoplasmbile ductscarbohydrate antigen 19-9 (CA19-9)Klatskin tumormargins of excision

Identifiers

PMID30221153
PMCPMC6131255

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.